tirzepatide italia 2024 prezzo Wegovy e Mounjaro, nuovi farmaci contro obesità non sono per tutti Terapia farmacologica per la cura

The authors declare no competing interests

Wegovy is also approved for the treatment of obesity

People with diabetes, especially those taking insulin or sulfonylureas, face increased hypoglycemia risk when consuming alcohol

Patients typically note reduced hunger during the day, quicker satiety, fewer cravings for high-calorie foods, and increased activity levels, alongside health improvements like lower blood pressure, cholesterol, and blood glucose levels

Information for healthcare professionals: Exenatide (marketed as Byetta)8/2008 update

Plateaus are often normal rest points The body sometimes pauses before making more changes